Celltrion, Inc. (KOSE: A068270)
Health Care · Biotechnology · KR
₩182,600.00
+2.93% today · +10.4% 1Y
Celltrion, Inc. (KOSE: A068270) operates in the Biotechnology industry within the Health Care sector. The company is valued at $30.97B.
Over the last twelve months the share price has gained 10.4%, trading between 158.50K and 239.05K.
Tweenvest scores Celltrion, Inc. across four factors: quality 74/100, value 69/100, growth 74/100, dividend 9/100. Its strongest factor is quality.
A068270 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $30.97B
- Revenue (TTM)
- $3.16B
- P/E
- 26.70
- EPS
- 6,840.22
- Dividend yield
- 0.39%
- Beta (5Y)
- 0.28
- 52-week high
- ₩239,047.62
- 52-week low
- ₩158,500.00
- Avg volume (3M)
- —
- Shares outstanding
- 228.43M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Natera, Inc.NasdaqGS: NTRA | $57.02B | $390.79 | -1.21% |
| Revolution Medicines, Inc.NasdaqGS: RVMD | $43.05B | $188.12 | -6.35% |
| BeOne Medicines AGNasdaqGS: ONC | $41.39B | $364.02 | +0.34% |
| Biogen Inc.NasdaqGS: BIIB | $32.82B | $218.43 | -1.67% |
| Alnylam Pharmaceuticals, Inc.NasdaqGS: ALNY | $30.03B | $224.53 | +0.05% |
| Roivant Sciences Ltd.NasdaqGS: ROIV | $25.10B | $34.21 | -1.55% |
| BioNTech SENasdaqGS: BNTX | $23.93B | $92.06 | -3.35% |
| United Therapeutics CorporationNasdaqGS: UTHR | $23.38B | $532.78 | -2.24% |
Figures last refreshed Oct 4, 2026.